Contact this trialFirst, we need to learn more about you.
Alkylating agents
Cyclophosphamide + Tacrolimus + Mycophenolate for Preventing Graft Versus Host Disease in Blood Cancers
Recruiting1 awardPhase 2
Duarte, California
This trial tests how well high doses of cyclophosphamide, tacrolimus, and mycophenolate mofetil prevent graft versus host disease in patients with blood cancer undergoing stem cell transplant.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.